# Enzalutamide Before Surgery in Treating Patients With Kidney Cancer

> **NCT02885649** · EARLY_PHASE1 · TERMINATED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 3 (actual)

## Conditions studied

- Clear Cell Renal Cell Carcinoma
- Stage I Renal Cell Cancer

## Interventions

- **DRUG:** Enzalutamide
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Nephrectomy

## Key facts

- **NCT ID:** NCT02885649
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-05
- **Primary completion:** 2020-03-02
- **Final completion:** 2020-03-02
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Funding unavailable
- **Last updated:** 2021-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02885649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02885649, "Enzalutamide Before Surgery in Treating Patients With Kidney Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02885649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*